Home
Products
Learn
About
Pricing
Log In
Back
CMB
Asset Logo

Cambium Bio Limited

πŸ‡¦πŸ‡Ί ASX

πŸ“ˆ HIGH PRICE GROWTH

🧬 BIOTECHNOLOGY

Compare
Add to watchlist
πŸ‘‘ Overview

πŸ“ˆ Performance

πŸ’΅ Cost

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

+ 35.13%
Annual Growth

5 years average annual capital growth

πŸ’΅

$ 500
Minimum Order

Due to regulatory requirements

🌏

0
Pearlers Invested

Since January 2020

πŸ‘‘ Overview

Key information
πŸ”Ž Fund Overview

Cambium Bio Ltd. engages in the development and commercialization of regenerative therapies derived from novel processed human platelets. Its technology, based on human platelet lysate, is being leveraged to create a pipeline of novel therapeutics, with a primary focus on ophthalmology. Its lead product candidate, Elate Ocular, is being developed to address significant unmet medical needs in the treatment of dry eye disease. Elate Ocular is formulated from the processing of base human platelets sourced not from patients, but generally healthier younger eligible donors at U.S. blood collection centers. In addition, its stem cell platform, Progenza, is being applied to the development of therapies for knee osteoarthritis and other tissue repair indications. The company also manufactures and sells stem cell growth supplements, such as UltraGRO Advanced, UltraGRO Pure (xeno-free), and UltraGRO Pure GI (xeno-free, gamma irradiated).

πŸ“ˆ Performance

Price History

+38.71%

1M

1Y

10Y

Graph

Table

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

N/A
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸ€“ Advanced information

Technical Info

πŸ’° Price*

$0.21

*Price may be up to 24 hours old

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in CMB

0

πŸ“Š Total Capital Earnings

N/A

πŸ”ƒ Average investment frequency

N/A

πŸ’΅ Average investment amount

N/A

⏰ Last time a customer invested in CMB

34 days
CMB investor breakdown
πŸ’΅ Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

πŸ‘Ά Age of investors

18 - 25

26 - 34

35 - 90

πŸ™‹ Legal gender of investors

Female

Male

Pearlers who invest in CMB also invest in...

Vanguard MSCI Index International Shares ETF

VGS

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

πŸ™Œ Performance (5Yr p.a)

16.68%

πŸ“Š Share price

$142.76 AUD

🌏 GLOBAL

πŸ€– TECHNOLOGY

⛳️ DIVERSIFIED

πŸ“ˆ HIGH PRICE GROWTH

Find Out More

IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

πŸ™Œ Performance (5Yr p.a)

21.90%

πŸ“Š Share price

$63.67 AUD

πŸ“ˆ HIGH PRICE GROWTH

πŸ‡ΊπŸ‡Έ UNITED STATES

Medibank Private Ltd. engages in the underwriting and distribution of private health insurance policies. The firm underwrites and distributes private health insurance policies under its two brands, Medibank and ahm. The company has two segments. Health Insurance segment offers private health insurance products including hospital cover and ancillary cover, as stand-alone products or packaged products that combine the two. Hospital cover provides members with health cover for hospital treatments, whereas ancillary cover provides members with health cover for healthcare services such as dental, optical and physiotherapy. Medibank Health segment is engaged in a range of activities including contracting with government and corporate customers to provide health management and in-home care services, as well as providing a range of telehealth services in Australia. In addition, it distributes travel, life and pet insurance products on behalf of other insurers as part of a strategy to retain members and leverage its distribution network.

πŸ™Œ Performance (5Yr p.a)

13.09%

πŸ“Š Share price

$5.03 AUD

πŸ‘©β€πŸ’Ό INSURANCE

πŸƒ HIGH ESG SCORE

🌳 ENVIRONMENTAL

πŸ•ŠοΈ SOCIALLY AWARE

πŸ“ˆ HIGH PRICE GROWTH

Qantas Airways Ltd. engages in international and domestic air transportation services. The company is headquartered in Mascot, New South Wales and currently employs 27,625 full-time employees. The principal activities of the Company include the operation of international and domestic air transportation services and provision of freight services and the operation of a frequent flyer loyalty program. The Company’s segments include Qantas Domestic, Qantas International, Jetstar Group, Qantas Loyalty, and Corporate. Qantas Domestic is a carrier in the Australian domestic market measured by capacity. Qantas Domestic offers on-board Wi-Fi and upgrades to the domestic lounges. Qantas International is a carrier into and out of Australia, also targeting business and premium leisure customers who value the full-service experience. Jetstar Group has domestic and international routes in Australia, joint ventures in Singapore and Japan. Qantas Loyalty is comprised of consumer and SME coalition loyalty programs. Its airline brands operate regional, domestic, and international services.

πŸ™Œ Performance (5Yr p.a)

38.80%

πŸ“Š Share price

$10.76 AUD

✈️ AIRLINES

🌳 ENVIRONMENTAL

πŸ•ŠοΈ SOCIALLY AWARE

πŸ“ˆ HIGH PRICE GROWTH

Strike Energy Ltd. engages in the business of exploring, developing, and producing activities related to oil and gas resources. The company is headquartered in Perth, Western Australia. The company went IPO on 2004-08-05. The firm is an independent gas producer, developer and explorer focused on its quality conventional gas resources in the Perth Basin. Its projects in the Perth Basin include the producing Walyering gas facility, South Erregulla peaking gas power project, West Erregulla and Ocean Hill. The Walyering gas field sits in production license L23. The field is situated approximately 150 km north of Perth near the town of Cataby in the Mid-West. The South Erregulla field sits within L 24 and EP 503. The company is situated approximately 350 km north of Perth near the town of Dongara in the Mid-West. The West Erregulla field sits within EP 469 which is operated and owned 50% by the Company. The Ocean Hill sits within EP495, situated approximately 350km north of Perth near the town of Eneabba. The firm also owns 100% of the geothermal rights in the Perth Basin, covering approximately 3,500 square kilometers (km2), namely The Precinct.

πŸ™Œ Performance (5Yr p.a)

-5.00%

πŸ“Š Share price

$0.15 AUD

⚑️ ENERGY

Want more shares? Try these...

πŸ™Œ Performance (5Yr p.a)

71.95%

πŸ“Š Share price

$0.40 AUD
Compare
Add to watchlist